Apr 8, 2026, 18:14
Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey
Simon Fletcher, Research Assistant at University of Oxford, shared a post on LinkedIn:
“In July I’m going to be in Paris at the ISTH 2026 congress sharing a novel psychosocial care framework for people undergoing gene therapy
for haemophilia.
After five years of research and clinical observation, the Exigency framework has been developed to address the unique challenges PwH face during their gene therapy journey.
What it will cover:
- Pre-treatment assessment
- Post-treatment monitoring
- Multidisciplinary care coordination strategies
- Patient support and education
Join me at the poster session on the 13th July to learn more about how this integrated approach can improve patient outcomes and quality of life.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support